Share
   
Title
Session Type
Venue
Date Time
Co-Chairs:

16:30
Introductions and overview of the session
16:40
Overview on HIV treatment and pregnancy including genetics, drugs, and pregnancy
Lynne Mofenson, Elizabeth Glaser Pediatric AIDS Foundation, United States
16:50
Surveillance for Neural Tube Defects following Antiretroviral Exposure from Conception, the Tsepamo study (Botswana)
Rebecca Zash, Beth Israel Deaconess Medical Center, United States
17:00
Data from other cohorts, regions to guide decisions
Meg Doherty, World Health Organization, Switzerland
17:10
Risks and benefits of dolutegravir (DTG)-based ART for women living with HIV of childbearing age in South Africa: A model-based analysis
Caitlin Dugdale, Medical Practice Evaluation Center, Massachusetts General Hospital, United States
17:20
Weighing up the risks and benefits
Maggie Little, Georgetown University, United States
17:30
Panel Discussion and Audience Q&A